Adobe Acrobat – A-national-health-emergency-by-Rajan-Madhok-Oct-2024.pdf
View this file, and add comments too.
Related Articles
Weather Impact Alert issued for Saturday due to threat of severe storms
The Houston area is under a Level 2 out of 5, meaning a slight risk for severe weather.
Longtime CBS Sports anchor Greg Gumbel dies at 78
He was a studio host of CBS Sports’ NCAA Division I Men’s Basketball coverage who had been covering sports for over 50 years.
Tell your Senators: Oppose Kennedy for Health and Human Services Secretary
Please contact Congress now!
Myeloma Paper of the Day, December 27th, suggested by Robert Orlowski – OncoDaily
Myeloma Paper of the Day, December 27th, suggested by Robert Orlowski / Ahmad Basharat, Ahmed Hebishy, cancer, hematopoietic stem cell transplant, Iqra Anwar,
Characterization of bleeding in thrombotic thrombocytopenic purpura in the precaplacizumab era: a retrospective nationwide analysis
The addition of caplacizumab to immune thrombotic thrombocytopenia (iTTP) treatment options has led to a renewed interest in characterizing the epidemiology and risk factors for…
Paper: Phase 3 Study of Teclistamab (Tec) in Combination with Lenalidomide (Len) and Tec Alone Versus Len Alone in Newly Diagnosed Multiple Myeloma (NDMM) As Maintenance Therapy Following Autologous Stem Cell Transplantation (ASCT): Safety Run-in (SRI) Results from the Majestec-4/EMN30 Trial
Program: Oral and Poster Abstracts Type: Oral Session: 654. Multiple Myeloma: Pharmacologic Therapies: Targeting BCMA Hematology Disease Topics & Pathways: Research, Clinical trials, Bispecific Antibody…
Hippopotomonstrosesquippedaliophobia: a made-up word for a made-up condition but I’m OK with that
Thagomizer, “the distinctive arrangement of four spikes on the tails of stegosaurian dinosaurs”, is a word that made the most unusual jump from a cartoon…
Maybe science isn’t completely a strong-link problem after all
I’m familiar with Adam Mastroianni’s thesis that science is a strong-link problem — here is at least one mention on this blog — and I…
MD-Granting Medical Schools in the US, 2023-2024
This Appendix presents data derived from the 2023-2024 Liaison Committee on Medical Education Annual Medical School Questionnaire-Part II.
FDA Approves Subcutaneous Nivolumab in Advanced or Metastatic Solid Tumors
The FDA has approved nivolumab and hyaluronidase-nvhy (Opdivo Qvantig) for subcutaneous injection across approved adult solid tumor nivolumab (Opdivo) indications.